GL1X · GenesisL1 explorer

Research workbench

WDR5 in complex with myc site fragment inhibitor

Analyse WDR5 in complex with myc site fragment inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6UHY
Type
protein
Length
605 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
WDR5
UniProt
P61964
Ligands
Q8G
Pockets
6 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 0% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AWDR5protein3010% helix, 53% strandP61964
BWDR5protein3040% helix, 50% strandP61964

Ligands and binding sites

  • Q8G · 1-cyclohexyl-1H-benzimidazole-5-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19300.820.8376empty
24910.740.8246empty
31940.560.8028empty
41750.510.7819empty
51210.400.7520empty

Interfaces

1 interface between chains.

  • A–B · 445 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 6UHY · WDR5 in complex with Myc site fragment inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.